United Therapeutic (UTHR)
$173.70 1.32 (0.77%)
17:25 EST UTHR Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 7.56B
PE Ratio 15.81
Volume (Avg. Vol.) 467,000
Day's Range 169.08 - 181.14
52-Week Range 75.58 - 181.14
Dividend & Yield N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeutic News
- From InvestorPlace
- From the Web
There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
MannKind scored a collaboration deal with biotechnology giant, United Therapeutics. This development partnership could pay off big.
United Therapeutics (UTHR) shares skyrocketed Friday amidst rumors that the company may be the subject of a takeover by a pharma giant soon.
3D Systems is up more than 20% so far this year, but DDD stock needs a first-quarter earnings beat to keep the momentum rolling.
Why General Motors Company (GM), Acorda Therapeutics Inc (ACOR) and United Therapeutics Corporation (UTHR) Are 3 of Today’s Worst Stocks
Acorda Therapeutics (ACOR), General Motors (GM) and United Therapeutics (UTHR) investors ended up wishing last weekend was a three-day weekend.
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Healthcare stocks finished up 0.3% on Wall Street on Thursday.
Healthcare stocks finished up 1.5% on Wall Street on Wednesday.
Healthcare stocks finished up 0.3% on Wall Street today.
Healthcare stocks rose 0.8% on Wall Street on Wednesday morning.
Healthcare stocks declined broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
From The Motley Fool
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Navellier RatingsPowered by Portfolio Grader